Effect of Empagliflozin on Liver Fat in Non-diabetic Patients

Clinical trial NCT04642261 · COMPLETED

Trial details

NCT number: NCT04642261
Sponsor: The University of Hong Kong
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Non-alcoholic Fatty Liver Disease

Start date: 2021-01-01
Primary completion: 2023-05-31
Enrollment: 98

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.